Cite
HARVARD Citation
Abou‐Alfa, G. et al. (2020). Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma. Oncologist. pp. e1837-e1845. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abou‐Alfa, G. et al. (2020). Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma. Oncologist. pp. e1837-e1845. [Online].